• Targeted mRNA Nanoparticles Repair the Poststroke BBB

  2026-09-15

  Gao and colleagues developed M2 microglia-targeting lipid nanoparticles that deliver interleukin-10 mRNA to ischemic brain lesions and reinforce an anti-inflammatory feedback loop. In mouse stroke models, the approach reduced neuroinflammation, improved blood–brain barrier integrity, limited neuronal apoptosis, and alleviated neurological deficits, with evidence suggesting a therapeutic window extending to 72 hours after stroke.

• G007-LK: Tankyrase 1/2 Inhibitor Workflows

  2026-09-14

  G007-LK enables controlled interrogation of tankyrase-dependent Wnt/β-catenin signaling, β-catenin turnover, and cancer-cell growth. Its strongest use cases span APC-mutant colorectal models, reporter assays, degradasome biology, and a carefully bounded extension into Hippo/YAP research.

• Ferroptosis Research Beyond a Rescue Compound

  2026-09-14

  Liproxstatin-1 HCl is more than a ferroptosis rescue reagent: it can serve as a mechanistic control, pathway-positioning tool, and translational bridge between lipid peroxidation biology and acute organ injury research.

• CIH, Gut Microbiota, and Mitochondrial Apoptosis

  2026-09-13

  This study integrates gut microbiome profiling, metabolomics, and mitochondrial apoptosis measurements to examine how chronic intermittent hypoxia damages the lung. Its pharmacological comparison of Mdivi-1 and CCCP links altered fatty acid metabolism and dysbiosis with mitochondrial injury, while also defining important limits on causal interpretation.

• Selonsertib (GS-4997) for Stress-Pathway Research

  2026-09-12

  Selonsertib (GS-4997) gives researchers a selective way to test whether ASK1 stress signaling contributes to autophagy failure, steatosis, inflammation, and fibrosis. This workflow pairs pathway inhibition with flux, lipid, and insulin-signaling readouts instead of treating ASK1 as a presumed upstream driver.

• Z-YVAD-FMK for Reliable Caspase-1 Assays

  2026-09-11

  Learn how Z-YVAD-FMK (SKU A8955) can strengthen mechanistic interpretation in apoptosis assays, pyroptosis research, and inflammasome activation studies. This practical guide covers model selection, controls, formulation, data interpretation, and supplier reliability.

• Clodronate Liposomes: Macrophage Depletion Workflows

  2026-09-10

  Clodronate Liposomes provide a practical way to test whether macrophages are required for injury, repair, or drug response in vivo. This guide connects phagocytosis-mediated delivery and apoptosis induction in macrophages with controls, tissue-specific workflows, single-cell readouts, and troubleshooting for liver ischemia-reperfusion research.

• GPR35–KLF5 Control of Epithelial Repair

  2026-09-09

  The reference study identifies a tryptophan–kynurenine–kynurenic acid sensing system in which GPR35 detects mucosal damage and signals through KLF5 and PI3K–AKT–mTOR to coordinate intestinal epithelial proliferation and migration. These findings provide a mechanistic framework for interpreting repair, rather than inflammation alone, in ulcerative colitis research and DSS-based intestinal injury models.

• Liproxstatin-1 HCl Ferroptosis Workflow

  2026-09-09

  Liproxstatin-1 HCl provides nanomolar ferroptosis rescue for cell-based lipid peroxidation studies and translational injury models. This workflow shows how to improve compound handling, distinguish ferroptosis from apoptosis, and connect mitochondrial calcium signaling to practical assay design.

• SU 5402: RTK Inhibition for Signaling Studies

  2026-09-08

  SU 5402 is a research inhibitor of VEGFR2, FGFR1, PDGFRβ, and EGFR signaling, with strongest reported activity against VEGFR2 and FGFR1. Its profile supports receptor tyrosine kinase studies in cancer biology and multiple myeloma research, but it does not by itself establish antiviral activity in human neuron models.

• Cy5-UTP: From RNA Labeling to LNP Insight

  2026-09-08

  Cy5-UTP can connect RNA probe synthesis with more rigorous mRNA delivery analytics. This thought-leadership guide examines how direct fluorescent labeling, simulation-guided lipid nanoparticle size control, and translational assay design can work together—while clearly separating established product utility from future LNP applications.

• Naftifine HCl in Antifungal Research Workflows

  2026-09-07

  Build more reproducible sterol-biosynthesis and fungal membrane assays with Naftifine HCl, from solvent preparation through orthogonal validation. The workflow also clarifies how this allylamine antifungal agent can inform mycology studies without being misapplied as a probe of the WNT5a/GSK3/β-catenin pathway.

• Lovastatin Workflows for HMG-CoA Reductase Studies

  2026-09-07

  Lovastatin enables controlled interrogation of cholesterol and isoprenoid depletion across cancer, fibroblast, mesangial-cell, and macrophage assays. This practical guide connects dose design, formulation control, orthogonal readouts, and a carefully bounded plant-development comparison.

• SOD Activity Assay: Reading Redox Biology Clearly

  2026-09-05

  The Superoxide Dismutase Activity Assay Kit enables a rapid colorimetric SOD Activity Assay based on WST-1 reduction. This guide explains what the signal means, how it differs from hydrogen peroxide assays, and how to build a defensible oxidative stress workflow.

• Self-Assembling EVMPs for Extrahepatic mRNA Delivery

  2026-09-04

  The reference study presents a bottom-up enveloped virus-mimicking particle (EVMP) that combines a computationally engineered self-assembling peptide with tissue-selective phospholipid envelopes for mRNA delivery beyond the liver. Optimized particles produced substantial lung-cell transfection and suppressed metastatic lung tumors with IL-12 mRNA, while the modular design offers a framework for improving tissue targeting and repeat dosing.

8438 records 1/563 page Next 12345 下5页 Last page